685 related articles for article (PubMed ID: 19860100)
21. A seven-year follow-up of a weight reduction programme in Finnish primary health care.
Karvetti RL; Hakala P
Eur J Clin Nutr; 1992 Oct; 46(10):743-52. PubMed ID: 1425528
[TBL] [Abstract][Full Text] [Related]
22. Effects of dietary intervention on weight loss and improvement of metabolic cormorbidities in a population of obese adults.
Rached-Amrouche C; Jamoussi-Kammoun H; BLouza-Chabchoub S
Tunis Med; 2007 Feb; 85(2):102-4. PubMed ID: 17665653
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of cognitive-behavioral therapy based on the Mediterranean diet for the treatment of obesity.
Corbalán MD; Morales EM; Canteras M; Espallardo A; Hernández T; Garaulet M
Nutrition; 2009; 25(7-8):861-9. PubMed ID: 19539176
[TBL] [Abstract][Full Text] [Related]
24. A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease.
Cook SA; MacLaughlin H; Macdougall IC
Nephrol Dial Transplant; 2008 Jan; 23(1):263-8. PubMed ID: 17977872
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients.
Chou KM; Huang BY; Fanchiang JK; Chen CH
Chang Gung Med J; 2007; 30(6):538-46. PubMed ID: 18350737
[TBL] [Abstract][Full Text] [Related]
26. The Solution Method: 2-year trends in weight, blood pressure, exercise, depression, and functioning of adults trained in development skills.
Mellin L; Croughan-Minihane M; Dickey L
J Am Diet Assoc; 1997 Oct; 97(10):1133-8. PubMed ID: 9336560
[TBL] [Abstract][Full Text] [Related]
27. Target value of intraabdominal fat area for improving coronary heart disease risk factors.
Tanaka K; Okura T; Shigematsu R; Nakata Y; Lee DJ; Wee SW; Yamabuki K
Obes Res; 2004 Apr; 12(4):695-703. PubMed ID: 15090639
[TBL] [Abstract][Full Text] [Related]
28. Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program.
Temple JL; Wrotniak BH; Paluch RA; Roemmich JN; Epstein LH
Int J Obes (Lond); 2006 Aug; 30(8):1260-4. PubMed ID: 16491111
[TBL] [Abstract][Full Text] [Related]
29. Preliminary report: the effect of a 6-month dietary glycemic index manipulation in addition to healthy eating advice and weight loss on arterial compliance and 24-hour ambulatory blood pressure in men: a pilot study.
Philippou E; Bovill-Taylor C; Rajkumar C; Vampa ML; Ntatsaki E; Brynes AE; Hickson M; Frost GS
Metabolism; 2009 Dec; 58(12):1703-8. PubMed ID: 19604522
[TBL] [Abstract][Full Text] [Related]
30. Randomized trial assessing the impact of a musculoskeletal intervention for pain before participating in a weight management program.
Snow R; Ruane J; LaLonde M; Shaffer L; Kim B; Graffagnino C; Falko J; Spencer K; Caulin-Glaser T
J Cardiopulm Rehabil Prev; 2010; 30(3):173-80. PubMed ID: 20040884
[TBL] [Abstract][Full Text] [Related]
31. Reduction of global cardiovascular risk with nutritional versus nutritional plus physical activity intervention in Colombian adults.
Mendivil CO; Cortés E; Sierra ID; Ramírez A; Molano LM; Tovar LE; Vargas C; Granados N; Pérez CE
Eur J Cardiovasc Prev Rehabil; 2006 Dec; 13(6):947-55. PubMed ID: 17143127
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of a pilot intervention program for overweight and obese adults at risk of type 2 diabetes].
Carrasco F; Moreno M; Irribarra V; Rodríguez L; Martin MA; Alarcón A; Mizón C; Echenique C; Saavedra V; Pizarra T; Atalah E
Rev Med Chil; 2008 Jan; 136(1):13-21. PubMed ID: 18483649
[TBL] [Abstract][Full Text] [Related]
33. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans.
Nagao T; Hase T; Tokimitsu I
Obesity (Silver Spring); 2007 Jun; 15(6):1473-83. PubMed ID: 17557985
[TBL] [Abstract][Full Text] [Related]
34. [Cardiovascular risk reduction: impact of an international project].
Colle B; Brusaferro S;
Ann Ig; 2008; 20(3 Suppl 1):43-8. PubMed ID: 18773604
[TBL] [Abstract][Full Text] [Related]
35. Overweight, obesity, and blood pressure: the effects of modest weight reduction.
Mertens IL; Van Gaal LF
Obes Res; 2000 May; 8(3):270-8. PubMed ID: 10832771
[TBL] [Abstract][Full Text] [Related]
36. A descriptive study of past experiences with weight-loss treatment.
Burke LE; Steenkiste A; Music E; Styn MA
J Am Diet Assoc; 2008 Apr; 108(4):640-7. PubMed ID: 18375220
[TBL] [Abstract][Full Text] [Related]
37. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
Andersson C; Weeke P; Fosbøl EL; Brendorp B; Køber L; Coutinho W; Sharma AM; Van Gaal L; Finer N; James WP; Caterson ID; Rode RA; Torp-Pedersen C; ;
Metabolism; 2009 Aug; 58(8):1109-15. PubMed ID: 19454355
[TBL] [Abstract][Full Text] [Related]
38. Translating the diabetes prevention program into practice in the general community: findings from the Montana Cardiovascular Disease and Diabetes Prevention Program.
Amundson HA; Butcher MK; Gohdes D; Hall TO; Harwell TS; Helgerson SD; Vanderwood KK;
Diabetes Educ; 2009; 35(2):209-10, 213-4, 216-20 passim. PubMed ID: 19321807
[TBL] [Abstract][Full Text] [Related]
39. Lowering the threshold for defining microalbuminuria: effects of a lifestyle-metformin intervention in obese "normoalbuminuric" non-diabetic subjects.
Cubeddu LX; Alfieri AB; Hoffmann IS
Am J Hypertens; 2008 Jan; 21(1):105-10. PubMed ID: 18091752
[TBL] [Abstract][Full Text] [Related]
40. A primary care intervention programme for obesity and coronary heart disease risk factor reduction.
Read A; Ramwell H; Storer H; Webber J
Br J Gen Pract; 2004 Apr; 54(501):272-8. PubMed ID: 15113494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
